Cargando…
Subconjunctival Bevacizumab for Primary Pterygium Excision; a Randomized Clinical Trial
PURPOSE: To evaluate the local safety of bevacizumab and its effect on recurrence of primary pterygium excision. METHODS: This randomized, placebo-controlled clinical trial was conducted on 44 eyes of 44 patients randomized to Group 1 (bevacizumab) and Group 2 (balanced salt solution). Group 1 under...
Autores principales: | Razeghinejad, Mohammad-Reza, Banifatemi, Mohammad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ophthalmic Research Center
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4074470/ https://www.ncbi.nlm.nih.gov/pubmed/24982728 |
Ejemplares similares
-
Comment on: Role of subconjunctival bevacizumab in primary pterygium surgery
por: Shivalli, Siddharudha, et al.
Publicado: (2016) -
Preoperative subconjunctival combined injection of bevacizumab and mitomycin C before the surgical excision of primary pterygium: clinical and histological results
por: Alsmman, Alahmady Hamad, et al.
Publicado: (2017) -
Efficacy of Subconjunctival Bevacizumab Injections before and after Surgical Excision in Preventing Pterygium Recurrence
por: Nuzzi, Raffaele, et al.
Publicado: (2017) -
A randomized controlled prospective study to assess the role of subconjunctival bevacizumab in primary pterygium surgery in Indian patients
por: Singh, Priyanka, et al.
Publicado: (2015) -
Comparison between the triamcinolone and bevacizumab subconjunctivals and changes in Interleukin-1 mRNA expression in pterygium
por: Syawal, Purnamanita, et al.
Publicado: (2021)